R1 RCM is a health information services business based in the US. R1 RCM shares (RCM) are listed on the NASDAQ and all prices are listed in US Dollars. R1 RCM employs 29,400 staff and has a trailing 12-month revenue of around $2.3 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $12.92 |
|---|---|
| 52-week range | $8.87 - $18.54 |
| 50-day moving average | $12.46 |
| 200-day moving average | $11.72 |
| Wall St. target price | $16.73 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.07 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $12.92 from 2024-07-25
| 1 week (2024-07-19) | -2.78% |
|---|---|
| 1 month (2024-06-26) | 2.62% |
| 3 months (2024-04-26) | 8.57% |
| 6 months (2024-01-26) | 24.83% |
| 1 year (2023-07-26) | -22.45% |
|---|---|
| 2 years (2022-07-22) | -46.57% |
| 3 years (2021-07-26) | 20.86 |
| 5 years (2019-07-26) | 13 |
Valuing R1 RCM stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of R1 RCM's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
R1 RCM's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.2155. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into R1 RCM's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
R1 RCM's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $538.3 million.
The EBITDA is a measure of a R1 RCM's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.3 billion |
|---|---|
| Operating margin TTM | 6.84% |
| Gross profit TTM | $361.3 million |
| Return on assets TTM | 2.85% |
| Return on equity TTM | -1.21% |
| Profit margin | -1.44% |
| Book value | $6.71 |
| Market Capitalization | $5.6 billion |
TTM: trailing 12 months
We're not expecting R1 RCM to pay a dividend over the next 12 months.
R1 RCM's shares were split on 21 June 2022.
Over the last 12 months, R1 RCM's shares have ranged in value from as little as $8.87 up to $18.535. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while R1 RCM's is 0.851. This would suggest that R1 RCM's shares are less volatile than average (for this exchange).
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah. .
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.